相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SM-368229, a Novel Promising Mineralocorticoid Receptor Antagonist, Shows Antihypertensive Efficacy With Minimal Effect on Serum Potassium Level in Rats
Tetsuro Nariai et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Diuretic use in renal disease
Domenic A. Sica
NATURE REVIEWS NEPHROLOGY (2012)
Antihypertensive and Cardiorenal Protective Effects of SM-368229, a Novel Mineralocorticoid Receptor Antagonist, in Aldosterone/Salt-Treated Rats
Tetsuro Nariai et al.
PHARMACOLOGY (2012)
Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial
David A. Calhoun et al.
CIRCULATION (2011)
Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
Matthew J. Volk et al.
CURRENT HYPERTENSION REPORTS (2011)
Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Femke Waanders et al.
CURRENT VASCULAR PHARMACOLOGY (2011)
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Y. Miao et al.
DIABETOLOGIA (2011)
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2011)
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
Frank A. Holtkamp et al.
EUROPEAN HEART JOURNAL (2011)
SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na+ Excretion Activity
Tetsuro Nariai et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
Rena J. Eudy et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
Lene Boesby et al.
PLOS ONE (2011)
Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors
Matthew R. Weir et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Aldosterone Synthase Inhibition With LCI699 A Proof-of-Concept Study in Patients With Primary Aldosteronism
Laurence Amar et al.
HYPERTENSION (2010)
A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
Jerome Fagart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring
Marsha A. Raebel et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2010)
Ion-Exchange Resins for the Treatment of Hyperkalemia: Are They Safe and Effective?
Richard H. Sterns et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Addition of Spironolactone to Dual Blockade of Renin Angiotensin System Dramatically Reduces Severe Proteinuria in Renal Transplant Patients: An Uncontrolled Pilot Study at 6 Months
E. Gonzalez Monte et al.
TRANSPLANTATION PROCEEDINGS (2010)
Aldosterone and inflammation
Kimberly C. Gilbert et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Pharmacodynamic and Pharmacokinetic Characterization of the Aldosterone Synthase Inhibitor FAD286 in Two Rodent Models of Hyperaldosteronism: Comparison with the 11β-Hydroxylase Inhibitor Metyrapone
Dean F. Rigel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Mechanisms of Impaired Potassium Handling With Dual Renin-Angiotensin-Aldosterone Blockade in Chronic Kidney Disease
Richard A. Preston et al.
HYPERTENSION (2009)
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Uzma F. Mehdi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt
William B. Lea et al.
KIDNEY INTERNATIONAL (2009)
Effect of Spironolactone on Urinary Protein Excretion in Patients with Chronic Kidney Disease
Erkan Sengul et al.
RENAL FAILURE (2009)
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: An open-label crossover randomized controlled trial
Leszek Tylicki et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Bertram Pitt et al.
CIRCULATION (2008)
RAS blockade with ARB and ACE inhibitors:: current perspective on rationale and patient selection
Christian Werner et al.
CLINICAL RESEARCH IN CARDIOLOGY (2008)
Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: Addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker
Yoshiyuki Furumatsu et al.
HYPERTENSION RESEARCH (2008)
The utility of the transtubular potassium gradient in the evaluation of hyperkalemia
Michael J. Choi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Incidence and predictors of hyperkalemia in patients with heart failure
Akshay S. Desai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Analysis of factors causing Hyperkalemia
Kenmei Takaichi et al.
INTERNAL MEDICINE (2007)
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004
Kwok Leung Ong et al.
HYPERTENSION (2007)
The incidence and implications of aldosterone breakthrough
Andrew S. Bomback et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
S. Bianchi et al.
KIDNEY INTERNATIONAL (2006)
Spironolactone in type 2 diabetic nephropathy: effects on proteinuria, blood pressure and renal function
Anton H. van den Meiracker et al.
JOURNAL OF HYPERTENSION (2006)
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
Murray Epstein et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt et al.
KIDNEY INTERNATIONAL (2006)
Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: A systematic review of the efficacy and safety data
Martin MacKinnon et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
Anastasia Chrysostomou et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Beneficial impact of spironolactone in diabetic nephropathy
KJ Schjoedt et al.
KIDNEY INTERNATIONAL (2005)
The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure
KB Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy - A randomized, double-masked, cross-over study
K Rossing et al.
DIABETES CARE (2005)
Antagonists of aldosterone and proteinuria in patients with CKD: An uncontrolled pilot study
S Bianchi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease
A Sato et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
D de Zeeuw et al.
CIRCULATION (2004)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
KJ Schjoedt et al.
DIABETOLOGIA (2004)
Distinguishing the antihypertensive and electrolyte effects of eplerenone
DG Levy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
D de Zeeuw et al.
KIDNEY INTERNATIONAL (2004)
Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule
P Meneton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
被撤回的出版物: The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study (Retracted article see vol 23, pg 818, 2006)
R Rachmani et al.
DIABETIC MEDICINE (2004)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
J Coresh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Safety of low-dose spironolactone administration in chronic haemodialysis patients
P Saudan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
A Sato et al.
HYPERTENSION (2003)
Monitoring of transtubular potassium gradient in the diuretic management of patients with cirrhosis and ascites
YS Lim et al.
LIVER (2002)
Hyperkalemia: An adaptive response in chronic renal insufficiency
FJ Gennari et al.
KIDNEY INTERNATIONAL (2002)
Calcium salts in management of hyperkalaemia
M Davey et al.
EMERGENCY MEDICINE JOURNAL (2002)
Hypokalaemia and hyperkalaemia
A Rastergar et al.
POSTGRADUATE MEDICAL JOURNAL (2001)
Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.
A Chrysostomou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Trans-tubular potassium gradient in patients with drug-induced hyperkalemia
H Mayan et al.
NEPHRON (2001)
Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications
M Epstein
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure
GL Bakris et al.
KIDNEY INTERNATIONAL (2000)
Electrocardiographic manifestations of hyperkalemia
A Mattu et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2000)
分享论文
